Patent: 4,557,934
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 4,557,934
Title: | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
Abstract: | Improved topical pharmaceutical compositions containing a pharmaceutically-active agent and the penetration enhancing agent 1-dodecylazacycloheptan-2-one are disclosed. This agent is used at selected levels in combination with certain C.sub.3 -C.sub.4 diols or a 1-substituted azacycloalkyl-2-one. This composition provides marked transepidermal and percutaneous delivery of the selected pharmaceutically-active agent. A method of treating certain pathologies and conditions responsive to the selected active, systemically or locally, is also disclosed. |
Inventor(s): | Cooper; Eugene R. (Cincinnati, OH) |
Assignee: | The Procter & Gamble Company (Cincinnati, OH) |
Application Number: | 06/506,275 |
Patent Claims: | see list of patent claims |
Details for Patent 4,557,934
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | See Plans and Pricing | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |